SlidesetHIVAsia-Pacific HIV Clinical Forum 2018Impact of Integrase Inhibitors on the HIV epidemic in Asia- Matthew Law, BA(Hons), MSc, PhDView Slideset
SKSaye KhooMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Clinical Pharmacology of Integrase Inhibitors - State of the Art- Saye Khoo, MD, PhDView Slideset
DKDaniel KuritzkesMDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Acquired Integrase Inhibitor Resistance - State of the Art- Daniel Kuritzkes, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2018Transmitted Integrase Inhibitor Resistance - State of the Art- Charles Boucher, MD, PhDView Slideset
SlidesetHIVCanadian HIV Clinical Forum 2018Novel drug delivery systems: will they have a place in routine HIV clinical care? (Not yet available)- Courtney Fletcher, PharmDView Slideset
GRGary RubinMD, MCFP, AAHIVSSlidesetHIVCanadian HIV Clinical Forum 2018Reduced drug regimens – Pros and Cons- Gary Rubin, MDView Slideset
SWSharon WalmsleyCM, MD, FRCPCSlidesetHIVCanadian HIV Clinical Forum 2018Improving care of HIV infected women: What needs to be done?- Sharon Walmsley, FRCPC, MD, MSCView Slideset
SlidesetHIVCanadian HIV Clinical Forum 2018Reducing HIV associated inflammation – do the drugs matter?- Darrell Tan, BSc, MD, FRCPC, PhDView Slideset
SlidesetHIVCanadian HIV Clinical Forum 2018Monitoring and avoiding integrase inhibitor toxicity- Gordon Arbess, MD, CCFPView Slideset
SlidesetHIVCanadian HIV Clinical Forum 2018State of the ART: What’s the same – what’s different – Is it clinicially relevant?- Eric Arts, PhDView Slideset
ATAlice TsengB.Sc.Phm., PharmD, FCSHP, AAHIVPSlidesetHIVCanadian HIV Clinical Forum 2018Managing drug-drug interactions in patients with multiple co-medications- Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVPView Slideset
CFCharles FlexnerMDSlidesetHIVCanadian HIV Clinical Forum 2018State of the ART: What’s the same – what’s different – is it clinicially relevant?- Charles Flexner, MDView Slideset
